124 related articles for article (PubMed ID: 1982141)
1. Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.
Coleman MD; Tingle MD; Winn MJ; Park BK
J Pharm Pharmacol; 1990 Oct; 42(10):698-703. PubMed ID: 1982141
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
Coleman MD; Russell RM; Tingle MD; Park BK
J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
Coleman MD; Tingle MD; Park BK
J Pharm Pharmacol; 1991 Mar; 43(3):186-90. PubMed ID: 1675276
[TBL] [Abstract][Full Text] [Related]
5. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
Tingle MD; Coleman MD; Park BK
Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
[TBL] [Abstract][Full Text] [Related]
6. The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.
Tingle MD; Park BK
Br J Clin Pharmacol; 1993 Jul; 36(1):31-8. PubMed ID: 8373710
[TBL] [Abstract][Full Text] [Related]
7. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
Tingle MD; Coleman MD; Park BK
Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.
Tingle MD; Mahmud R; Maggs JL; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1997 Nov; 283(2):817-23. PubMed ID: 9353403
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
[TBL] [Abstract][Full Text] [Related]
10. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro.
Coleman MD; Jacobus DP
Biochem Pharmacol; 1993 Mar; 45(5):1027-33. PubMed ID: 8461032
[TBL] [Abstract][Full Text] [Related]
11. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Irshaid Y; Adedoyin A; Lotze M; Branch RA
Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
[TBL] [Abstract][Full Text] [Related]
12. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma.
Coleman MD; Jacobus DP
Biochem Pharmacol; 1993 Oct; 46(8):1363-8. PubMed ID: 8240384
[TBL] [Abstract][Full Text] [Related]
13. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
Coleman MD; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1989 Oct; 28(4):389-95. PubMed ID: 2590600
[TBL] [Abstract][Full Text] [Related]
14. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
Reilly TP; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
[TBL] [Abstract][Full Text] [Related]
15. N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.
Uehleke H; Tabarelli S
Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):55-68. PubMed ID: 4145470
[No Abstract] [Full Text] [Related]
16. Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.
Riley RJ; Roberts P; Coleman MD; Kitteringham NR; Park BK
Br J Clin Pharmacol; 1990 Sep; 30(3):417-26. PubMed ID: 2223420
[TBL] [Abstract][Full Text] [Related]
17. The effect of pregnenolone 16alpha-carbonitrile on the pharmacokinetics and metabolism of dapsone in rats.
Lu M; Poloyac SM; McNamara PJ; Blouin RA
J Pharm Pharmacol; 1999 Jul; 51(7):803-10. PubMed ID: 10467955
[TBL] [Abstract][Full Text] [Related]
18. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
Coleman MD; Scott AK; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
[TBL] [Abstract][Full Text] [Related]
19. Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systems.
Coleman MD; Smith SN; Kelly DE; Kelly SL; Seydel JK
J Pharm Pharmacol; 1996 Sep; 48(9):945-50. PubMed ID: 8910859
[TBL] [Abstract][Full Text] [Related]
20. Sulfamethazine as a model compound to assess sex hormone-dependent cytochrome P-450 activity in rats.
Witkamp RF; Nijmeijer SM; Yun H; Noordhoek J; van Miert AS
Drug Metab Dispos; 1993; 21(3):441-6. PubMed ID: 8100499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
